FRM
Fox Run Management’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $400K | Buy |
+2,637
| New | +$400K | 0.07% | 548 |
|
2023
Q2 | – | Sell |
-4,320
| Closed | -$872K | – | 743 |
|
2023
Q1 | $872K | Buy |
+4,320
| New | +$872K | 0.28% | 90 |
|
2022
Q3 | – | Sell |
-2,549
| Closed | -$545K | – | 641 |
|
2022
Q2 | $545K | Buy |
+2,549
| New | +$545K | 0.27% | 101 |
|
2020
Q3 | – | Sell |
-1,154
| Closed | -$201K | – | 198 |
|
2020
Q2 | $201K | Buy |
+1,154
| New | +$201K | 0.27% | 215 |
|
2019
Q1 | – | Sell |
-7,116
| Closed | -$805K | – | 502 |
|
2018
Q4 | $805K | Buy |
+7,116
| New | +$805K | 0.43% | 20 |
|
2018
Q2 | – | Sell |
-6,660
| Closed | -$711K | – | 707 |
|
2018
Q1 | $711K | Buy |
+6,660
| New | +$711K | 0.17% | 190 |
|
2017
Q4 | – | Sell |
-4,400
| Closed | -$475K | – | 702 |
|
2017
Q3 | $475K | Buy |
+4,400
| New | +$475K | 0.13% | 311 |
|
2017
Q2 | – | Sell |
-7,400
| Closed | -$666K | – | 664 |
|
2017
Q1 | $666K | Sell |
7,400
-2,700
| -27% | -$243K | 0.27% | 97 |
|
2016
Q4 | $770K | Buy |
10,100
+1,200
| +13% | +$91.5K | 0.4% | 26 |
|
2016
Q3 | $742K | Sell |
8,900
-300
| -3% | -$25K | 0.44% | 20 |
|
2016
Q2 | $758K | Buy |
+9,200
| New | +$758K | 0.37% | 30 |
|